Gossamer Bio, Inc.
GOSS
$2.00
-$0.04-1.96%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -36.64M | -33.03M | -30.80M | 49.23M | -41.93M |
| Total Depreciation and Amortization | 342.00K | 1.08M | 1.10M | 992.00K | 986.00K |
| Total Amortization of Deferred Charges | 241.00K | 238.00K | 234.00K | 321.00K | 293.00K |
| Total Other Non-Cash Items | -262.00K | 1.79M | 1.49M | 2.01M | 3.08M |
| Change in Net Operating Assets | -3.41M | -5.55M | -4.05M | 63.80M | -14.73M |
| Cash from Operations | -39.72M | -35.48M | -32.03M | 116.35M | -52.30M |
| Capital Expenditure | -26.00K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.09M | 53.22M | -26.75M | -59.11M | 61.67M |
| Cash from Investing | 22.06M | 53.22M | -26.75M | -59.11M | 61.67M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | 0.00 | -9.68M | -2.90M |
| Issuance of Common Stock | 504.00K | 0.00 | 281.00K | 0.00 | 348.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00 | 0.00 | 464.00K | -- |
| Cash from Financing | 504.00K | 0.00 | 281.00K | -9.21M | -2.56M |
| Foreign Exchange rate Adjustments | 105.00K | -125.00K | 93.00K | -8.00K | -62.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -17.05M | 17.61M | -58.41M | 48.01M | 6.75M |